Prof. Tomas Deierborg joins the NOSA advisory board

Professor Tomas Deierborg becomes the newest addition to NOSA as senior scientific advisor.

Professor Deierborg is Head of Department at Department of Experimental Medical Science and Research team manager at Neuroinflammation at Lund University.

Tomas is a professor and neuroscientist with extensive experience in clinical research and has worked closely with several leading pharmaceutical companies.

Tomas brings extensive expertise from his career as a neuroscientist. Known for his contributions to the understanding of neurodegenerative diseases such as Alzheimer’s, stroke and Parkinson’s, he has published research in journals such as Nature, with coverage in media outlets such as CNN and The New York Times. He has also been CEO of a medtech company and has received leadership awards. With a dedicated focus on unraveling the complexities of neuroinflammation within the brain, Professor Deierborg’s work at the Neuroinflammation Lab has helped drive the translation of pioneering research into clinically tested interventions. Now entrusted with leading a department housing over 70 research groups spanning diverse fields ranging from structural biology and pharmacology to diabetes, lung diseases, neuroscience, vascular research, and bioinformatics, Professor Deierborg will contribute his experience and interdisciplinary perspective to NOSA.

We welcome Tomas to the team and look forward to taking the next steps in the NOSA drug delivery project together.